Rare Disease Day: Recognizing the needs of those with rare conditions

Rare Disease Day 2019

With over 350 million patients currently diagnosed with a rare disease worldwide, what makes a rare disease ‘rare’? With the growing need for medical translations in research and patents, CSOFT bridges the gap of global healthcare.

FDA approval can be challenging, requiring expert support

First Treatment of the Rare Disease aTTP Gains FDA Approval

The FDA has approved the first treatment for the rare disease acquired Thrombotic Thrombocytopenic Purpura or aTTP for short. This rare disease occurs in less than .001% of the population and before had no cure.

FDA approved generic drugs are essential to keeping drugs affordable

First Generic Inhaler of Advair Diskus Becomes FDA Approved

On January 30, 2019, the FDA approved the first generic version of Advair Diskus. This popular inhaler medication is one of the most commonly used prescriptions for treating Asthma and Chronic Obstruction Pulmonary Disease (COPD). This new license will provide patients with access to more affordable prescriptions. This advancement will also affect the drug market in other parts of the world.